|
INSIG2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09170003540038E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.69190000290465E-08 |
| Normal-vs-Stage2 |
2.69159999954915E-07 |
| Normal-vs-Stage3 |
1.0529999999731E-06 |
| Normal-vs-Stage4 |
9.89099999681997E-08 |
| Stage1-vs-Stage2 |
2.205200E-01 |
| Stage1-vs-Stage3 |
8.424600E-01 |
| Stage1-vs-Stage4 |
3.617600E-01 |
| Stage2-vs-Stage3 |
3.575400E-01 |
| Stage2-vs-Stage4 |
7.628400E-01 |
| Stage3-vs-Stage4 |
4.754000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.22940000402139E-08 |
| Normal-vs-AfricanAmerican |
1.629770E-04 |
| Normal-vs-Asian |
2.11609999999363E-05 |
| Caucasian-vs-AfricanAmerican |
8.670800E-01 |
| Caucasian-vs-Asian |
6.900400E-01 |
| AfricanAmerican-vs-Asian |
6.511000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.43790000017852E-07 |
| Normal-vs-Female |
3.94010002402467E-09 |
| Male-vs-Female |
9.710000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.6740999998528E-07 |
| Normal-vs-Age(41-60Yrs) |
9.73060000353243E-08 |
| Normal-vs-Age(61-80Yrs) |
1.59089963425174E-10 |
| Normal-vs-Age(81-100Yrs) |
9.620100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.125600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.449900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.209200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.672600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.104600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.476350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.799600E-01 |
| Classical-VS-Follicular |
3.761800E-03 |
| Classical-VS-Other |
7.499800E-01 |
| Classical-VS-Normal |
8.08329999602009E-08 |
| Tall-VS-Follicular |
1.515980E-02 |
| Tall-VS-Other |
4.718000E-01 |
| Tall-VS-Normal |
1.270310E-02 |
| Follicular-VS-Other |
5.599600E-01 |
| Follicular-VS-Normal |
2.80459999668636E-09 |
| Other-VS-Normal |
2.431800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19970000600489E-09 |
| Normal-vs-N1 |
8.19930000006686E-07 |
| N0-vs-N1 |
8.882400E-01 |
|
|
